King’s Health Partners (KHP) is governed and supported by these groups:
The KHP Board
The KHP Board sets and drives the strategy for King's Health Partners. It is chaired by the Principal of King's College London and includes the Chairs and Chief Executives of the three Foundation Trusts, the Senior Vice President, Service, People and Planning for King's College London, the Executive Director, Managing Director and Independent Chair of King's Health Partners.
The KHP Board meets six times a year and oversees our major partnerships, developing our priorities and strategy. It is responsible for driving the delivery of our five-year plan and ensuring the benefits are realised across the health and life sciences agenda; locally, nationally and internationally. To view the minutes and agendas from previous KHP Joint Board meetings, click here.
The KHP Executive Group
The KHP Executive Group was formed in 2021 following our governance review and refresh. The Executive Group drives and challenges progress and delivery of our five-year plan.
It is responsible for ensuring we make the most of our assets and links as a national and global partnership, and as we do so it ensures that our work and how we communicate about our work is aligned to our partners. It offers King’s Health Partners oversight of the pace and development of all of our major programmes and activities.
It meets quarterly and is formed of a group of representatives from across King’s Health Partners including Medical Directors, Strategy Directors, Site Chief Executive and School Deans. Attendance from King’s Health Partners includes our Executive Director and Managing Director, the Director of Partnerships and Programmes, Mind and Body Director and key programme Directors as needed.
Membership also includes the Health Innovation Network Chief Executive and Chief Operating Officer, and the Directors of the NIHR Guy’s and St Thomas’ BRC and Maudsley BRC.
The KHP System Innovation Forum
The KHP System Innovation Forum was formed in 2021 following our governance review and refresh. It meets twice a year and focuses on theme 1 within our five-year plan; novel technologies, therapeutics and diagnostics.
Its aim is to maximise the potential of our commercial partnerships across life sciences, education, therapeutics and technologies. It will drive our work in digital and informatics and address the national life sciences agenda and Government Vision, including through the development of SC1.
Its membership was forged to bring together the breadth of scientific and leadership expertise, including representatives from partners of King’s Health Partners and the Health Innovation Network, the Executive Director and Managing Director of King’s Health Partners, the Directors of the NIHR Guy’s and St Thomas’ BRC and Maudsley BRC, the Director of the NIHR Applied Research Collaborative South London, the Chair and Managing Director of KHP Med Tech JV, the Executive Director and Project Director of the SC1 Innovation District and the ICS Chair, Clinical Chair and Director of Commissioning, from SEL ICS and SWL ICS.
CAG Leaders and key programmes and partnerships
To drive the development, impact and operation of our Clinical Academic Groups (CAGs), CAG Leaders meetings occur bi-monthly.
Our key programmes and partnerships, including KHP Neurosciences, KHP Haematology, KHP Women’s and Children’s Health, KHP Diabetes, Endocrinology and Obesity, KHP Cardiovascular and Respiratory Partnership Programme and KHP Mind and Body all form their own programme Boards to drive operational delivery.